1. Imatinib Mesylate Inhibits CD4+CD25+ Regulatory T Cell Activity and Enhances Active Immunotherapy against BCR-ABL− Tumors
   Nicolas Larmonier et al, 2008, The Journal of Immunology CrossRef
2. Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias
   Julian Swatler et al, 2021, Cancers CrossRef
3. Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies
   Joshua S. Davis et al, 2020, Clinical Microbiology Reviews CrossRef